Mechanical aspects of CO2 angiograpgy: technical validation of Angiodroid CO2 injector has been published on Pysica Medica
The article is available at following site:
http://dx.doi.org/10.1016/j.ejmp.2011.11.003
Gemelli Hospital Gym in Rome reopening – the show must go on!
2011, october 1st – The Gym is open!
After 3 monts of preparations, SPLS s.r.l. (a NewCo shared by SparkBIO) reopened the famous gym located into the CEMI department of Gemelli Hospital in Rome.
More that 500 guest already confirmed their subscription to the Gym.
LIMPE 2011 congress
More than 80 doctors assisted to the live demo of Light System during the course about methods in authonomic nervous system during Limpre 2011 congress.
Software platform for Parkinson aided diagnosis
SparkBIO presents the first software platform for Parkinson aided diagnosis developed in cooperation with neurosciences institute of Bologna University in Italy.
First scientific pubblications are awaited within november 2011.
SparkBIO is the main sponsor at “Methods of neurovegetative system evaluation”, Neurosciences department – Bologna University
SparkBIO is the main sponsor at “Methods of neurovegetative system evaluation”, Neurosciences Institute of Bologna University – sep 23, 2011
Angiodroid CO2 injector and Philips Medical Systems angiographic devices integration
Ends development of technical integration of Angiodroid CO2 injector with Philips Medical Systems angiographic equipments.
The picture is an example of results during a carbon dioxide injection made at Villa Maria Cecilia Hospital in Cotignola (RA – Italy).
Cardiac Rehabilitation Platform
Started CE mark procedure for Cardiac Rehabilitation Platform (CRP), the innovative web based/telemedicine platform for cardiac rehabilitation management
Finapres Medical Systems exclusive distribution for Italy
SparkBIO is the new Italian national distributor for Finapres Medical Systems B.V.
CE mark approval for Anidroid CO2 automatic injector
CE mark approval for Angiodroid CO2 automatic injector; it’s finally possible to make angiographic procedure without iodinated contrast fluids, reducing to zero CIN risk (contrast induced nephropathy) for patient.